Biodesix, Inc. (BDSX)

NASDAQ: BDSX · IEX Real-Time Price · USD
1.48
-0.13 (-8.07%)
At close: May 20, 2022 4:00 PM
1.54
0.06 (4.05%)
After-hours:May 20, 2022 5:51 PM EDT

Ratios and Metrics (Trailing)

Millions USD. Fiscal year is Jan - Dec.
Period EndedCurrent2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-31
Market Capitalization
5953143222355540535
Market Cap Growth
--90.20%-73.29%----
Enterprise Value
5549120204332518501
PE Ratio
--1.02-3.31-6.44-11.18-18.87-17.07
PS Ratio
1.831.642.622.984.617.7911.75
PB Ratio
7.576.807.2513.8313.7714.8213.00
EV/Sales Ratio
1.700.942.292.674.327.2912.79
Debt / Equity Ratio
1.591.590.511.871.280.910.67
Debt / EBITDA Ratio
-0.29-0.29-0.28-1.09-1.38-1.75-1.33
Debt / FCF Ratio
-0.38-0.38-0.33-1.03-1.30-1.08-1.18
Current Ratio
0.910.911.512.483.225.042.68
Asset Turnover
0.390.390.570.690.800.840.55
Return on Equity (ROE)
-298.80%-298.80%-176.20%-115.30%83.60%27.00%34.10%
Return on Assets (ROA)
-62.90%-62.90%-45.00%-32.10%-33.00%-34.80%-37.70%
Return on Capital (ROIC)
-363.30%-363.30%-156.00%-96.20%-91.40%-84.70%-96.40%
Earnings Yield
-87.93%-97.87%-30.19%-15.52%-8.95%-5.30%-5.86%
FCF Yield
-54.98%-61.20%-21.53%-13.18%-7.18%-5.69%-4.40%
Buyback Yield / Dilution
-16.79%-16.79%-465.63%-10026.72%-9983.64%--1899.17%
Total Shareholder Return
-16.79%-16.79%-465.63%-10026.72%-9983.64%0.00%-1899.17%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).